Showing results (21-30 of 396) with videos related to
Sort By:
Pageof 40
European Heart Journal|June 12, 2015
Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetesEle Ferrannini, Ralph A DeFronzoJournal of Hypertension|January 22, 2005
Enhanced angiotensin II-mediated effects in fibroblasts of patients with familial hypercholesterolemiaAnna Solini, Eleonora Santini, Ele FerranniniThe Journal of Clinical Endocrinology and Metabolism|April 5, 2002
Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled studyNadia Caraccio, Ele Ferrannini, Fabio MonzaniDiabetes Care|June 12, 2016
CV Protection in the EMPA-REG OUTCOME Trial: A "Thrifty Substrate" HypothesisEle Ferrannini, Michael Mark, Eric MayouxEuropean Heart Journal|March 27, 2003
Erythrocyte sedimentation rate, coronary atherosclerosis, and cardiac mortalityAndrea Natali, Antonio L'Abbate, Ele FerranniniThe Medical Clinics of North America|February 2, 2011
Pathophysiology of prediabetesEle Ferrannini, Amalia Gastaldelli, Patricia IozzoDiabetologia|March 4, 2014
Canagliflozin, a sodium glucose co-transporter 2 inhibitor, improves model-based indices of beta cell function in patients with type 2 diabetesDavid Polidori, Andrea Mari, Ele FerranniniHypertension (Dallas, Tex. : 1979)|September 4, 2003
Relation between left ventricular midwall function and coronary vasodilator capacity in arterial hypertensionMichaela Kozàkovà, Ele Ferrannini, Carlo PalomboDiabetes Care|January 29, 2020
Coronary Artery Disease and Type 2 Diabetes: A Proteomic StudyGiulia Ferrannini, Maria Laura Manca, Marco Magnoni, et al.The American Journal of Clinical Nutrition|August 8, 2014
The threshold shift paradigm of obesity: evidence from surgically induced weight lossEle Ferrannini, Michael Rosenbaum, Rudolph L LeibelPageof 40